GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 3SBio, Inc. (FRA:YFK) » Definitions » Short Percentage of Float

3SBio, (FRA:YFK) Short Percentage of Float


View and export this data going back to . Start your Free Trial

What is 3SBio, Short Percentage of Float?

Short Percentage of Float is the percentage of shares shorted compared to the float.

Due to the license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus website.

Competitive Comparison of 3SBio,'s Short Percentage of Float

For the Biotechnology subindustry, 3SBio,'s Short Percentage of Float, along with its competitors' market caps and Short Percentage of Float data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

3SBio,'s Short Percentage of Float Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, 3SBio,'s Short Percentage of Float distribution charts can be found below:

* The bar in red indicates where 3SBio,'s Short Percentage of Float falls into.


3SBio, (FRA:YFK) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 3SBio, Inc. (FRA:YFK) » Definitions » Short Percentage of Float
Comparable Companies
RFL ROCO:3176 APLT CABA SRRK GRTX OSMT UBX TPE:4142 GRTS OYST SZSE:002286 CRBP TSE:7774 ROCO:6712 SZSE:002868 CDMO SZSE:002898 UROV KIN
Traded in Other Exchanges
N/A
Address
Website
http://www.3sbio.com
3SBio Inc is engaged in the healthcare sector based in China. It is a pharmaceutical products company and its core activities pertain to developing, manufacturing and marketing biopharmaceuticals. Its portfolio of products comprises of TPIAO and Yisaipu. TPIAO is the only commercialized recombinant human thrombopoietin (rhTPO) product in the world and Yisaipu is a TNF inhibibator product and accounts for the major share in the pharmaceutical industry in China. Most of the company's activities are focused on China while having a minor footprint in a foreign land.

3SBio, (FRA:YFK) Headlines

No Headlines